402 related articles for article (PubMed ID: 23921838)
1. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
[TBL] [Abstract][Full Text] [Related]
3. Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage.
Kalmadi S; Tiu R; Lowe C; Jin T; Kalaycio M
Cancer; 2006 Jul; 107(1):136-40. PubMed ID: 16708357
[TBL] [Abstract][Full Text] [Related]
4. The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial.
Estcourt LJ; McQuilten Z; Powter G; Dyer C; Curnow E; Wood EM; Stanworth SJ;
Trials; 2019 Oct; 20(1):592. PubMed ID: 31615553
[TBL] [Abstract][Full Text] [Related]
5. Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series.
Marshall A; Li A; Drucker A; Dzik W
Hematol Oncol; 2016 Sep; 34(3):147-53. PubMed ID: 25641349
[TBL] [Abstract][Full Text] [Related]
6. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
[TBL] [Abstract][Full Text] [Related]
7. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
[TBL] [Abstract][Full Text] [Related]
8. Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients.
Garewal HS; Durie BG
Scand J Haematol; 1985 Nov; 35(5):497-500. PubMed ID: 4089529
[TBL] [Abstract][Full Text] [Related]
9. The effect of ε-aminocaproic acid on blood product requirement, outcome and thromboelastography parameters in severely thrombocytopenic dogs.
Wolf J; Ruterbories LK; Handel I; Hansen B
J Vet Intern Med; 2024; 38(2):1013-1021. PubMed ID: 38206934
[TBL] [Abstract][Full Text] [Related]
10. The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting.
Ypma PF; Kerkhoffs JL; van Hilten JA; Middelburg RA; Coccoris M; Zwaginga JJ; Beckers EM; Fijnheer R; van der Meer PF; Brand A
Transfus Med; 2012 Dec; 22(6):426-31. PubMed ID: 23036067
[TBL] [Abstract][Full Text] [Related]
11. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic complications following aminocaproic acid use in patients with hematologic malignancies.
Juhl RC; Roddy JVF; Wang TF; Li J; Elefritz JL
Leuk Lymphoma; 2018 Oct; 59(10):2377-2382. PubMed ID: 29424601
[TBL] [Abstract][Full Text] [Related]
13. Dental extraction in the thrombocytopenic patient is safe and complications are easily managed.
Fillmore WJ; Leavitt BD; Arce K
J Oral Maxillofac Surg; 2013 Oct; 71(10):1647-52. PubMed ID: 23932116
[TBL] [Abstract][Full Text] [Related]
14. An audit of platelet transfusion within the Wellington Cancer Centre.
Buhrkuhl DC; Karlsson MK; Carter JM
Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
[TBL] [Abstract][Full Text] [Related]
16. Platelet transfusions and bleeding complications associated with plasma exchange catheter placement in patients with presumed thrombotic thrombocytopenic purpura.
Duffy SM; Coyle TE
J Clin Apher; 2013 Oct; 28(5):356-8. PubMed ID: 23720092
[TBL] [Abstract][Full Text] [Related]
17. Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia?
Chakrabarti S; Varma S; Singh S; Kumari S
Eur J Haematol; 1998 May; 60(5):313-4. PubMed ID: 9654162
[No Abstract] [Full Text] [Related]
18. Blood loss and transfusion requirements with epsilon-aminocaproic acid use during cranial vault reconstruction surgery.
Thompson ME; Saadeh C; Watkins P; Nagy L; Demke J
J Clin Anesth; 2017 Feb; 36():153-157. PubMed ID: 28183556
[TBL] [Abstract][Full Text] [Related]
19. Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.
Stanworth SJ; Hudson CL; Estcourt LJ; Johnson RJ; Wood EM;
Haematologica; 2015 Jun; 100(6):740-7. PubMed ID: 25795717
[TBL] [Abstract][Full Text] [Related]
20. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
